| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | EP0479903B1 Substituted imidazoles useful as angiotensin ii blockers |
| 02/21/1996 | CN1117266A Stable protein: phospholipid compositions and methods |
| 02/21/1996 | CN1031059C Method for preparation of 7-oxa-bi-eycloheptyl substituted heterocyclic amide prostaglandin analogs |
| 02/21/1996 | CN1031057C Preparation of triazolo |4,3-a¨|1,4¨ benzodiazepine and thiapheno |3,2-f¨|1,2,4¨ triazolo |4,3-a¨|1,4¨diazepine derivatives |
| 02/21/1996 | CN1031051C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 02/20/1996 | US5493020 Tricyclic inhibitors of the GPIIb IIIa receptor |
| 02/20/1996 | US5493007 Oligopeptide |
| 02/20/1996 | US5492895 Inhibitors of thrombosis |
| 02/20/1996 | CA2018211C Modified hvi-type hirudin and process for the manufacture thereof |
| 02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | WO1996004280A1 Phenyl xanthine derivatives |
| 02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/14/1996 | EP0696455A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 02/14/1996 | EP0696199A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 02/14/1996 | CN1116847A N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists |
| 02/14/1996 | CN1116628A Cyclopeptides of the formulal |
| 02/14/1996 | CA2155920A1 Use of interferon for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells |
| 02/13/1996 | US5491142 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 02/13/1996 | US5491141 Enzyme inhibitors, hypertensive agents; treating diuretic, congestive heart failure, aldosteronism, renal diseases, glaucoma |
| 02/13/1996 | US5491129 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | WO1996003430A1 Organic compounds |
| 02/08/1996 | WO1996003426A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 02/08/1996 | WO1996003411A1 D-mannose or xylitol esters and their use as drugs |
| 02/08/1996 | WO1996003374A1 Thrombin inhibitors |
| 02/08/1996 | WO1996003143A1 Methods for treating bleeding disorders |
| 02/08/1996 | CA2196091A1 D-mannose or xylitol esters and their use as drugs |
| 02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | CA2195630A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 02/08/1996 | CA2193844A1 Thrombin inhibitors |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 02/07/1996 | EP0695346A1 Human erythroid progenitor cell population |
| 02/06/1996 | US5489693 Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes preparing them |
| 02/06/1996 | US5489611 Method for lowering plasma levels of lipoprotein (a) |
| 02/06/1996 | US5489594 Anticoagulants |
| 02/06/1996 | US5489583 2-substituted 3-(4-amidinophenyl)propionic acid derivatives |
| 02/05/1996 | CA2155245A1 Use of neutortensin antagonists for the preparation of diuretic drugs |
| 02/01/1996 | WO1996002571A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 02/01/1996 | WO1996002522A1 Natriuretic and anti-hypertensive compounds |
| 02/01/1996 | WO1995013385A3 Thrombin mutants |
| 01/31/1996 | EP0694536A1 1-Benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them |
| 01/31/1996 | EP0694033A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
| 01/31/1996 | EP0693930A1 Use of colloidal silicon dioxide for treating sickle-cell anemia, malaria and exogenously induced leukopenias |
| 01/31/1996 | EP0693925A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | EP0590132A4 -i(in vitro)-derived human neutrophil precursor cells |
| 01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace |
| 01/30/1996 | US5488037 Antithrombotic agents |
| 01/30/1996 | US5487892 Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
| 01/30/1996 | US5487891 Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents |
| 01/30/1996 | CA1338012C Pharmaceutically active amines |
| 01/25/1996 | WO1996001649A1 Method of attenuating arterial stenosis |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194443A1 Method of attenuating arterial stenosis |
| 01/24/1996 | EP0693083A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 01/24/1996 | EP0693067A1 Fibrinogen receptor antagonists |
| 01/24/1996 | EP0692984A1 Systemic effects of nitric oxide inhalation |
| 01/24/1996 | EP0610334B1 Nonpeptidyl integrin inhibitors having specificity for the gpii b iii a receptor |
| 01/23/1996 | US5486602 Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| 01/23/1996 | US5486531 Angina, hypotensive agents, erectile dysfunction |
| 01/23/1996 | US5486529 Certain pyridyl ketones for treating diseases involving leukocyte elastase |
| 01/23/1996 | US5486525 Platelet activating factor antagonists: imidazopyridine indoles |
| 01/23/1996 | US5486513 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors or enkephalinase and ace |
| 01/23/1996 | CA1337969C Stable emulsions of highly fluorinated organic compounds |
| 01/18/1996 | WO1996001118A1 Biochemically balanced peritoneal dialysis solutions |
| 01/18/1996 | WO1996001116A1 Chicken infectious anemia virus vaccine |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0691987A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 01/17/1996 | EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
| 01/17/1996 | EP0691959A1 Heterocyclic derivatives as platelet aggregation inhibitors |
| 01/17/1996 | EP0691953A1 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | EP0314705B1 A novel family of primate hematopoietic growth factors |
| 01/17/1996 | CN1115182A Antithrombotic |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/16/1996 | US5484946 Cyclization and dehydration a methionine derivative |
| 01/16/1996 | US5484808 Methods of inhibiting cell-cell adhesion |
| 01/16/1996 | US5484772 Arginine aldehyde compounds as anticoagulants or treatment of thromboembolitic agents |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/14/1996 | CA2153720A1 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 01/11/1996 | WO1996000577A1 Agents affecting thrombosis hemostasis |
| 01/11/1996 | CA2190642A1 Agents affecting thrombosis and hemostasis |
| 01/10/1996 | EP0691403A1 Family of primate IP-3-like hemapoietic growth factors |
| 01/10/1996 | EP0691350A2 uPA binding sites on domain 2+3 on uPAR and antibodies reactive therewith |
| 01/10/1996 | EP0691130A1 Use of rapamycin in the manufacture of a medicament for preventing and heating hyperproliferactive vascular diseases, eventually in combination with mycophenolic acid |
| 01/10/1996 | EP0690991A1 Novel anticoagulant cofactor activity |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690847A1 Heterocyclic compounds as platelet aggregation inhibitors |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0690671A1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 01/10/1996 | EP0558570B1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/10/1996 | EP0558529B1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 01/10/1996 | CN1114836A Displacement chromatography process and purified hemoglobin product |
| 01/09/1996 | US5482953 2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharmaceuticals |
| 01/09/1996 | US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds |
| 01/09/1996 | CA2153208A1 Upa binding sites on domain 2+3 on upar and antibodies reactive therewith |
| 01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |